NCT01845129

Brief Summary

The present study assesses whether language functions in patients with residual post-stroke aphasia can be improved by transcranial direct current stimulation administered to the primary motor cortex in the language dominant (left) hemisphere.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2013

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

April 30, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 3, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

May 3, 2013

Status Verified

April 1, 2013

Enrollment Period

1 year

First QC Date

April 30, 2013

Last Update Submit

April 30, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Response latency during picture naming task (max. 80)

    Subjects are assessed in a cross-over design. The primary outcome measure will be assessed twice in each subject, either during placebo ("sham) stimulation or active (anodal) stimulation with transcranial direct current stimulation. Order of stimulation will be counterbalanced across the group.

    Change in response latency between assessment 1 (week 1) and assessment 2 (week 2), assessments 1 and 2 are seperated by one week

Secondary Outcomes (1)

  • Change in neural activity measured by functional magnetic resonance imaging

    Change in fMRI activity between Assessment 1 (week 1) and Assessment 2 (week 2), assessments 1 and 2 are seperated by one week

Study Arms (2)

anodal tDCS

EXPERIMENTAL

atDCS will be administered for 20 minutes with 1 milliampere (1 mA) to the left primary hand motor cortex

Device: atDCSDevice: sham tDCS

sham tDCS

SHAM COMPARATOR

sham tDCS will be administered to the left primary hand motor cortex

Device: atDCSDevice: sham tDCS

Interventions

atDCSDEVICE

atDCS will be delivered with a constant current of 1 mA during simultaneous resting-state (RS) and task-related (picture naming) functional magnetic resonance imaging (fMRI). The current will be turned on prior to the RS-fMRI scan and continues for 20 minutes.

anodal tDCSsham tDCS
sham tDCSDEVICE

During sham the current will be increeased and decreased in a ramp-like fashion (10 sec)

anodal tDCSsham tDCS

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • right handedness
  • German native speaker
  • cerebrovascular stroke in left hemisphere (\>6 months)
  • mild aphasia (according to Aachen Aphasia Test Battery Classification, Huber et al., 1983)
  • residual anomia in naming test (\>75 correct responses)

You may not qualify if:

  • other current or previous neurological or psychiatric diseases
  • alcohol or drug abuse
  • MRI contraindication (e.g. magnetic metal, pacemaker, claustrophobia)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charite, University Medicine, Dept. of Neurology

Berlin, State of Berlin, 10117, Germany

RECRUITING

Study Officials

  • Marcus Meinzer, PhD

    Charite, University Medicine, Neurology

    PRINCIPAL INVESTIGATOR
  • Agnes Flöel, MD

    Charite, University Medicine, Neurology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Creutzfeldt Fellow

Study Record Dates

First Submitted

April 30, 2013

First Posted

May 3, 2013

Study Start

April 1, 2013

Primary Completion

April 1, 2014

Study Completion

April 1, 2014

Last Updated

May 3, 2013

Record last verified: 2013-04

Locations